The identification of high frequency of somatic NF1 mutations in sporadic tumours indicates that neurofibromin is likely to play a critical role in development, far beyond that evident in the tumour predisposition syndrome NF1. The gene discussed is NF1; the disease is BAP1-related tumor predisposition syndrome.